Benefits of ACCRUFeR
An iron treatment designed for tolerability and optimized absorption
ACCRUFeR® (ferric maltol) is an effective, low-dose treatment for patients with iron deficiency (ID) or iron deficiency anemia (IDA).
Why ACCRUFeR?
ACCRUFeR is FDA approved for adults and children 10 years of age and older with ID and IDA.
ACCRUFeR was studied in patients with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and chronic kidney disease (stages 3 or 4). It's clinically proven to treat ID and IDA, even in patients who typically struggle with tolerability and iron absorption.
And, it’s affordable. Eligible patients can get ACCRUFeR for as little as $0 with our copay card.*
*Restrictions apply.
Reasons ACCRUFeR may be right for you
Patented MALTOL SHIELDTM
The iron in ACCRUFeR is shielded by a substance called maltol. The MALTOL SHIELDTM keeps iron protected from the stomach, so it doesn’t break down until it is ready to be absorbed in the small intestine. By limiting the amount of unabsorbed iron in the body, there is a lower risk for intolerable gastrointestinal (GI) side effects.
Unprecedented tolerability
Across studies, fewer than 5% of patients taking ACCRUFeR discontinued treatment because of GI side effects.*
*Total of 175 patients across studies
Just enough iron
Patients take a low 30 mg dose of ACCRUFeR twice per day. With this dosing, treatment in clinical studies did not lead to iron overload.
Iron you’ll actually take
Up to 60% of people will stop taking traditional oral iron supplements because of negative GI side effects. In ACCRUFeR's clinical studies, side effects were considered mild to moderate in nature. Some of the most common side effects included gas, diarrhea, constipation, discolored feces, and abdominal pain.
Fewer than 5% of the individual patients taking ACCRUFeR (out of 175) reported each of the individual GI-related side effects.